This chapter looks at pregnant mothers and the physiology of pregnancy. It describes how to look after these patients after operations they experience during their pregnancy as well as after Caesarean section. Instructions are given for the special care of newborn infants. Problems of postpartum haemorrhage, eclampsia, air and amniotic embolism, and aspiration pneumonia are discussed.
This chapter looks at pregnant mothers and the physiology of pregnancy. It describes how to look after these patients after operations they experience during their pregnancy as well as after Caesarean section. Instructions are given for the special care of newborn infants. Problems of postpartum haemorrhage, eclampsia, air and amniotic embolism, and aspiration pneumonia are discussed.
Abstract
Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings .This study aimed to evaluate the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. Methods: A decision tree model was used to estimate the cost-effectiveness of HFNC compared with oxygen by nasal cannula (control strategy) in an infant with bronchiolitis in the emergency setting. Cost data were obtained from a retrospective study on bronchiolitis from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Results:The QALYs per patient calculated in the base-case model were 0.9141 (95% CI 0.913- 0.915) in the HFNC and 0.9105 (95% CI 0.910- 0.911) in control group. The cost per patient was US$368 (95% CI US$ 323- 411) in HFNC and US$441 (95% CI US$ 384-498) per patient in the control group.Conclusions: HFNC in emergency settings was cost-effective for the hospital treatment of an infant with bronchiolitis
Nasal High-Flow for Early Respiratory Support of Newborn Infants in Australian Non-Tertiary Special Care Nurseries (The Hunter Trial): A Multicentre, Randomised, Non-Inferiority Trial
